Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.
Fiskus W, Mill CP, Bose P, Masarova L, Pemmaraju N, Dunbar A, Birdwell C, Davis JA, Das K, Hou H, Manshouri T, Jain A, Malovannaya A, Philip K, Alhamadani N, Matthews A, Lin K, Flores L, Loghavi S, DiNardo CD, Su X, Rampal RK, Bhalla KN. Fiskus W, et al. Among authors: pemmaraju n. Blood. 2024 Nov 19:blood.2024026388. doi: 10.1182/blood.2024026388. Online ahead of print. Blood. 2024. PMID: 39561280
A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms.
Bouligny IM, Montalban-Bravo G, Sasaki K, Daver N, Jabbour E, Alvarado Y, DiNardo CD, Ravandi F, Borthakur G, Pemmaraju N, Kadia T, Masarova L, Takahashi K, Andreeff M, Bazinet A, Yang H, Kanagal R, Pierce S, Meyer M, Huang X, Garcia-Manero G. Bouligny IM, et al. Among authors: pemmaraju n. Leukemia. 2024 Nov 17. doi: 10.1038/s41375-024-02457-7. Online ahead of print. Leukemia. 2024. PMID: 39551874 No abstract available.
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: pemmaraju n. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
Unexpected Mediastinal Mass Etiology in B-Acute Lymphoblastic Leukemia.
Phan L, Jabbour E, Antonoff MB, Jain N, Lin P, Moran C, Pemmaraju N. Phan L, et al. Among authors: pemmaraju n. J Immunother Precis Oncol. 2024 Nov 1;7(4):314-316. doi: 10.36401/JIPO-24-9. eCollection 2024 Nov. J Immunother Precis Oncol. 2024. PMID: 39524462 Free PMC article.
How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kharfan-Dabaja MA, Lane AA, Pemmaraju N. Kharfan-Dabaja MA, et al. Among authors: pemmaraju n. Blood. 2024 Oct 7:blood.2024024262. doi: 10.1182/blood.2024024262. Online ahead of print. Blood. 2024. PMID: 39374520
Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial.
Short NJ, Nguyen D, Jabbour E, Senapati J, Zeng Z, Issa GC, Abbas H, Nasnas C, Qiao W, Huang X, Borthakur G, Chien K, Haddad FG, Pemmaraju N, Karrar OS, Nguyen D, Konopleva M, Kantarjian H, Ravandi F. Short NJ, et al. Among authors: pemmaraju n. Lancet Haematol. 2024 Nov;11(11):e839-e849. doi: 10.1016/S2352-3026(24)00250-3. Epub 2024 Sep 17. Lancet Haematol. 2024. PMID: 39303729 Clinical Trial.
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.
DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, Saxena K, Cai T, Su X, Guerra VA, Poigaialwar G, Kuruvilla VM, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Hackman GL, Chaudhry S, Collins M, Sweeney SR, Busquets J, Rathore AS, Deng Q, Green MR, Grant S, Demo S, Choudhary GS, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett GD, Burger J, Borthakur G, Jabbour E, Pemmaraju N, Kadia T, Kornblau S, Daver NG, Naqvi K, Short NJ, Garcia-Manero G, Tiziani S, Verma A, Konopleva M. DiNardo CD, et al. Among authors: pemmaraju n. Nat Cancer. 2024 Oct;5(10):1515-1533. doi: 10.1038/s43018-024-00811-3. Epub 2024 Sep 19. Nat Cancer. 2024. PMID: 39300320 Clinical Trial.
405 results